$PFE Recent News AstraZeneca, Smith & Nephew push FTSE

New Post Public Reply Private Reply Replies (0) Message Board

Apr 27, 2014 at 9:37 AM

$PFE Recent News

AstraZeneca, Smith & Nephew push FTSE to 7-week high 12:31 p.m. April 24, 2014 - Sara Sjolin
In focus: Challenging the all-time highs 9:45 p.m. April 23, 2014 - Lawrence G. McMillan
Glaxo, AstraZeneca lead U.K. stocks to two-week high 12:50 p.m. April 22, 2014 - Carla Mozee
Drug stocks drive European markets higher 12:22 p.m. April 22, 2014 - Carla Mozee
Pfizer Psoriasis treatment shows positive results 9:35 a.m. April 22, 2014 - MarketWatch.com
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
European stocks rise as AstraZeneca, Glaxo climb 3:40 a.m. April 22, 2014 - Carla Mozee
Investors drive up AstraZeneca despite questions over potential Pfizer deal 12:00 p.m. April 21, 2014 - blogs.marketwatch.com
Pfizer held now-discontinued talks with AstraZeneca: report 2:18 a.m. April 21, 2014 - Barbara Kollmeyer
Acura Pharmaceuticals ends Pfizer licensing pact 7:10 a.m. April 10, 2014 - MarketWatch.com
U.S. stocks fall; Nasdaq 3-day loss worst since 2011 4:48 p.m. April 7, 2014 - Victor Reklaitis
Newscast: Wall Street extends recent selloff 4:28 p.m. April 7, 2014 - MarketWatch
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Ben Eisen
Pfizer shares drop despite positive test for breast-cancer drug 1:03 p.m. April 7, 2014 - blogs.marketwatch.com
Pfizer drops 2.5% to lead Dow decliners 9:35 a.m. April 7, 2014 - William L. Watts
How sector stock funds can make your portfolio whole 7:01 a.m. April 7, 2014 - Jonathan Burton
Best, worst stocks of the $100 billion club: Morgan Stanley 2:03 p.m. March 31, 2014 - blogs.marketwatch.com
Pfizer anti-cholesterol drug meets main study goal 9:28 a.m. March 27, 2014 - MarketWatch.com
Apple looks ready to head higher 3:48 p.m. March 17, 2014 - blogs.marketwatch.com
Apple as the Comeback Kid 1:13 p.m. March 13, 2014 - Mark Hulbert

Biotech: The Poster Child for Market Volatility in 2014 7:32 a.m. April 26, 2014 - 247WallSt.com
Assessing Pfizer's Future 3:43 a.m. April 26, 2014 - Barrons.com
Stocks Fall Slightly After a Jittery Friday 1:44 a.m. April 26, 2014 - Barrons.com
Is The Vanguard High Dividend Yield ETF Primed For Dividend Growth? 6:04 p.m. April 25, 2014 - Seeking Alpha
Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2014 Update 1:31 p.m. April 25, 2014 - Seeking Alpha
FDA Reviewing Psychiatric Side Effects of Pfizer's Chantix 11:50 a.m. April 25, 2014 - The Wall Street Journal Interactive Edition
Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix 10:34 a.m. April 25, 2014 - Seeking Alpha
AstraZeneca Misses Earnings But Up on Takeover Rumors - Analyst Blog 10:30 a.m. April 25, 2014 - Zacks.com
Cramer's Mad Money - Revenge Of The Nerds (4/24/14) 6:45 a.m. April 25, 2014 - Seeking Alpha
2 Clear Signs That Biotechs and Pharmaceuticals Have Peaked 5:55 a.m. April 25, 2014 - InvestorPlace.com
Generics Dent AstraZeneca Profit 3:12 p.m. April 24, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca (AZN) Stock Higher Over Pfizer (PFE) Takeover Talk As Earnings Drop 12:31 p.m. April 24, 2014 - TheStreet.com
AstraZeneca Suffering from Split Personality 11:27 a.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Actavis Settles Celebrex Case With Pfizer 11:03 a.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Dow Today: Pfizer (PFE) Lower 11:00 a.m. April 24, 2014 - TheStreet.com
Trade-Ideas: Pfizer (PFE) Is Today's "Roof Leaker" Stock 10:12 a.m. April 24, 2014 - TheStreet.com
AstraZeneca could sell, spin off $15B worth of assets 7:59 a.m. April 24, 2014 - Seeking Alpha
30 And Under Portfolio: Q1 2014 Update 6:45 a.m. April 24, 2014 - Seeking Alpha
Merck, P&G and Other Dividend Stocks You Wish You'd Bought in 2013 6:00 a.m. April 24, 2014 - TheStreet.com
European Stocks Rebound Amid M&A, Earnings Headlines 5:56 a.m. April 24, 2014 - TheStreet.com

Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Pfizer Hosts Annual Meeting of ShareholdersDeclares 26-Cent Second-Quarter 2014 Dividend 10:50 a.m. April 24, 2014 - BusinessWire - BZX
Actavis Announces Celebrex® Patent Challenge Settlement 9:20 a.m. April 24, 2014 - PR Newswire - PRF
Active Equities under the Scanner -- Research on JPMorgan Chase, Pfizer, General Motors, and Nokia 1:13 p.m. April 22, 2014 - PR Newswire - PRF
Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis 8:01 a.m. April 22, 2014 - BusinessWire - BZX
Promotional Campaigns, Equity Awards, Stock Price Movements, New Launches, and Company Events - Analyst Notes on Pfizer, Intuitive Surgical, HCA Holdings, General Electric and John Deere 8:00 a.m. April 21, 2014 - PR Newswire - PRF
Pfizer Invites Public to Listen to Webcast of April 24 Annual Meeting of Shareholders 1:20 p.m. April 18, 2014 - BusinessWire - BZX
Brain Cancer Global Clinical Trials Review, H1, 2014 12:25 p.m. April 17, 2014 - PR Newswire - PRF
Premier Biomedical (BIEI) and the Wild West of Modern Medicine 10:25 a.m. April 14, 2014 - ACCESSWIRE
GlycoMimetics Announces Presentation of Data on Rivipansel (GMI-1070) in Combination with Current FDA-Approved Treatment for Sickle Cell Disease 9:02 a.m. April 14, 2014 - BusinessWire - BZX
Priority Reviews, Preliminary Earnings Releases, Clinical Trials Results, and Launch of Website - Analyst Notes on Gilead, Pfizer, Intuitive Surgical, Alkermes and Quest 10:14 a.m. April 11, 2014 - PR Newswire - PRF
Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts 9:00 a.m. April 11, 2014 - BusinessWire - BZX
Acura Pharmaceuticals Announces Return of Product Rights 6:15 a.m. April 10, 2014 - Marketwire
Thyroid Cancer Global Clinical Trials Review, H2, 2013 1:29 p.m. April 9, 2014 - PR Newswire - PRF
Enrollment in Expansion Phase of Trials, Results and Initiation of Phase 2 Studies and Stock Movements - Analyst Notes on Pfizer, Cytokinetics, Portola Pharmaceuticals, Volcano, and Array BioPharma 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Diabetic Macular Edema Global Clinical Trials Review, H2, 2013 10:32 a.m. April 8, 2014 - PR Newswire - PRF
NDA Filings, FDA Approvals, Executive Appointments, Ceased Clinical Trials, and Public Offerings - Analyst Notes on Johnson & Johnson, Pfizer, Merck, GSK, and Intercept 8:00 a.m. April 7, 2014 - PR Newswire - PRF
Pfizer’s Novel CDK 4/6 Inhibitor Palbociclib plus Letrozole Significantly Prolonged Progression-Free Survival in Patients with Advanced Breast Cancer 10:30 a.m. April 6, 2014 - BusinessWire - BZX
AMCP Foundation Launches Initiative to Identify Emerging Medication Management Practices that Can Advance Patient Care and Outcomes; Project Supported by Pfizer 12:38 p.m. April 3, 2014 - PR Newswire - PRF
Exosomes Shine a Light on Alzheimer's Disease and CTE 10:16 a.m. April 3, 2014 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Prison Film 'Basement People' Reaches Nationwide Audience

Prison Creativity Finds a Wider Stage Out from behind bars, some stories still have a long way to travel—but make no mistake, when they do, they pack a punch. “Basement People,” a short film penned by incarcerated writer Kyale Akeem Williams, is making its rounds and stirring up attention as if its origins were pure Hollywood. This film has taken a noteworthy path...

CashorTrade and Front Gate Unite for Ticket Resale

Big News for Festival Enthusiasts Imagine the scene: you've snagged tickets to the hottest festival of the year—maybe Lollapalooza or Austin City Limits—but life throws a curveball, and you can't go. That's where CashorTrade and Front Gate Tickets come in, forming a dynamic duo for festival-goers who need to swap tickets at face value. It’s like a lifeline for every...

GAC All-New E8 Debuts at 2026 Macao Auto Expo

Revving Up at the Macao Auto Expo Sometimes it feels like the car game’s all about who can shout louder with a new model line-up. And there, under the bright lights of the Venetian Macao Cotai Expo, GAC rolled out their ALL-NEW E8. This wasn’t just another car in their roster; it's the symbol of their steady climb up the ranks and a nod to their decade-long presence...

Gastops and Bell: A New Era in Aerospace Collaboration

Gastops and Bell Seal a Forward-Looking Deal Who would've thought Gastops and Bell, two juggernauts in their respective fields, would link arms to drive the aerospace game forward in Canada? That's right, a Memorandum of Understanding (MOU) was inked between these titans at the 2026 Canadian Aerospace Summit, paving the way for collaboration on future programs. This isn't...

Texas Home Boasts PGA-Caliber Green with Synthetic Turf

Swinging for Luxury in Your Backyard Who'd have thought that a chunk of Austin, Texas, could boast a putting green that’s giving any PGA course a run for its money? We’re talking about a family here who decided they’d had enough of scalding summers and winter chills and wanted a taste of that country club glam at home without the upkeep headaches. The Rise of...

The Sift: Slickdeals’ Game-Changing Black Friday Tool

Revolutionizing Black Friday Planning Off we go, diving headfirst into the chaotic whirlpool that is Black Friday shopping. Slickdeals seems to think they’ve got the golden ticket with The Sift, and I can't say they're wrong. Instead of the traditional paper ad scans we've been sifting through since the dawn of time, The Sift brings all announced deals into one...

Vivek Ramaswamy's Executive Orders: A Bold Move

It appears Vivek Ramaswamy is gearing up to clear the decks and bring a wave of changes to Ohio as soon as he grabs the governor's chair. With a first-day agenda packed tighter than a can of sardines, Ramaswamy plans to drop seven executive orders like they're hot. The guy announced his Day One priorities, giving us a real taste of what Ohio might be in for starting...

Home Selling in Henderson County: Tips from Experts

An Insider's View on Selling Homes in Henderson County Ace up, folks—selling a home isn't child's play. Courtney Robertson, a seasoned real estate expert, lays out the bare truth about what sellers need to know when putting their property on the market in Henderson County, Texas. This isn’t just about slapping on paint and praying for buyers. Nope, there's a lot more...

Kansas City Life's Q3: Earnings Dip, but Growth Ahead

Striking a Balance: Kansas City Life's Q3 They say numbers don’t lie, and Kansas City Life Insurance just shared their latest. This quarter, things weren't all smooth sailing, but there's a silver lining. For Q3 2026, net income clocked in at $1.7 million, or $0.18 per share, down from last year’s $2.8 million, or $0.29 per share. Sure, it wasn't all sunshine and...

Millrose Properties Faces Legal Storm: Investors Alerted

Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...